Evaluation of blood pressure lowering effect by generic and brand-name antihypertensive drugs treatment: a multicenter prospective study in China-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Evaluation of blood pressure lowering effect by generic and brand-name antihypertensive drugs treatment: a multicenter prospective study in China

Published:2021-01-19 Issue:3 Volume:134 Page:292-301
ISSN:0366-6999
Container-title:Chinese Medical Journal
language:en
Short-container-title:

Author:

Zhang Shu-Yuan,Tao Li-Yuan,Yang Yun-Yun,Kong Tao,Wu Cun-Jin,Wang Yang,Chen Jing-Zhou,Song Lei,Wang Yi-Bo,Hui Ru-Tai,Zhang Wei-Li

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine,General Medicine

Reference28 articles.

1. Rapid health transition in China, 1990-2010: findings from the global burden of disease study 2010;Yang;Lancet,2013

2. Prevalence, awareness, treatment, and control of hypertension in China: data from 1.7 million adults in a population-based screening study (China PEACE million persons project);Lu;Lancet,2017

3. China Hypertension Survey Investigators. Status of hypertension in China: results from the China hypertension survey, 2012-2015;Wang;Circulation,2018

4. The cost-effectiveness of low-cost essential antihypertensive medicines for hypertension control in China: a modelling study;Gu;PLoS Med,2015

5. Access to antihypertensive drugs in China;Bai;Circulation,2018

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Report on cardiovascular health and diseases in China 2021: an updated summary;Journal of Geriatric Cardiology;2023-06

2. Variation in Price of Cardiovascular and Diabetes Medicine in Indonesia, and Relationship with Quality: A Mixed Methods Study in East Java;The American Journal of Tropical Medicine and Hygiene;2023-05-09

3. Variation in price of cardiovascular and diabetes medicine in Indonesia, and relationship with quality: a mixed methods study in East Java;2022-11-27

4. Report on Cardiovascular Health and Diseases in China 2021: An Updated Summary;BIOMED ENVIRON SCI;2022

5. Rapid Approach for Pharmaceutical Quality Evaluation and Comparison;ChemistrySelect;2022-05-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3